| NDC Code | 43602-395-05 |
|---|
| Package Description | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-395-05) |
|---|
| Product NDC | 43602-395 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Venlafaxine Hydrochloride |
|---|
| Non-Proprietary Name | Venlafaxine |
|---|
| Dosage Form | TABLET, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20201023 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA214419 |
|---|
| Manufacturer | Ascent Pharmaceuticals, Inc. |
|---|
| Substance Name | VENLAFAXINE HYDROCHLORIDE |
|---|
| Strength | 225 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
|---|